TechsoMed
1 known investors
TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction. The system serves physicians performing ablation procedures, compressing imaging frames into a single interface for full-cycle ablation management.
Founders & leadership
YA
Yossi Abu
DM
Dasy Mandel
NE
Nitzan Even
YZ
Yogev Zohar
DF
Dubi Finklshtein
Investors · 1
Frequently asked questions
- What does TechsoMed do?
- TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction. The system serves physicians performing ablation procedures, compressing imaging frames into a single interface for full-cycle ablation management.
- Who are TechsoMed's investors?
- TechsoMed's investors include NextLeap Ventures.